© 2024 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement
<< Back To Article
Growth in Infectious Disease Drugs at Bristol-Myers Squibb

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

Dave Martin

Of course infectious disease is affected by the economy. It rises. HIV infection, whether from sex or drug use, is higher amongst lower-income persons. BMS knows this. And all they care about - evidenced by their "hopes" of high revenue - is profit. When will we stand up and demand the price of crucial, life-saving medication for all potentially fatal illnesses be regulated? The federal government could used the money saved on ADAP to fund research for cures.

October 28, 2010 • Austin

Advertisement

Hot topics

Forums: Support and discussion
Blogs: The community speaks
POZ Stories: Get inspired
Magazine: Search the archives
HIV: The Basics
Recursos de VIH/SIDA en Español
AIDS Is Everyday
Ask POZ

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.